Abstract P073: Pharmacological inhibition of IRAK4 with CA-4948 is beneficial in marginal zone lymphoma models with secondary resistance to PI3K and BTK inhibitors

2021 ◽  
Author(s):  
Francesca Guidetti ◽  
Alberto J. Arribas ◽  
Filippo Spriano ◽  
Laura Barnabei ◽  
Reinhard von Roemeling ◽  
...  
Keyword(s):  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Secondary Resistance ◽  
Pharmacological Inhibition ◽  
Btk Inhibitors

scholarly journals MECHANISMS OF SECONDARY RESISTANCE TO IDELALISIB IN MARGINAL ZONE LYMPHOMA

2019 ◽  
Vol 37 ◽  
pp. 319-319
Author(s):  
A. Arribas ◽  
S. Napoli ◽  
E. Gaudio ◽  
L. Cascione ◽  
A. Di Veroli ◽  
...  
Keyword(s):  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Secondary Resistance

Abstract 906: Development of novel preclinical models of secondary resistance downstream B cell receptor in marginal zone lymphoma

2018 ◽  
Author(s):  
Alberto J. Arribas ◽  
Eugenio Gaudio ◽  
Luciano Cascione ◽  
Chiara Tarantelli ◽  
Antonella Zucchetto ◽  
...  
Keyword(s):  
B Cell ◽  
Marginal Zone ◽  
Cell Receptor ◽  
Marginal Zone Lymphoma ◽  
B Cell Receptor ◽  
Preclinical Models ◽  
Secondary Resistance

Secondary resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma

2020 ◽  
Vol 138 ◽  
pp. S40
Author(s):  
A. Arribas ◽  
S. Napoli ◽  
L. Cascione ◽  
E. Gaudio ◽  
R. Bordone-Pittau ◽  
...  
Keyword(s):  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Pi3k Inhibitor ◽  
Secondary Resistance
Sign in / Sign up

Export Citation Format

Share Document